Strange, it works for me. I hope seek the light doesn't mind if I quote that message:
"In the case of IPIX, i believe management has done a very good job of dealing with the many obstacles they have face over the years. The most devastating of which was the untruthful attack of the unscrupulous short sellers crowd. AF is a tool of and works for these unscrupulous shorts and has for all his shoddy journalistic life even when he started in SF Ca.
These repeated attacks had the effect of making the capital raising that is the lifeblood of startup bio techs much more difficult for management. This has lead to more dilution than most are comfortable with, but the good news is the company has Three viable drug candidates with B having immense upside potential. B is the equivalent of a drug platform [meaning many possible indications] in and of itself. And given the potential the shares outstanding is quite reasonable.
The most profitable Bio Tech i ever invested in was IMCLONE. Imclone was also attacked by AF and his band of short sellers and Martha and Sam went to jail, but the drug [only had one then] was good and the shares went from less than $1 to $70. You can look it up.
The good news is IPIX has THREE drug canidates. All having more potential than the Imclone drug. JMO!"
News 
Market Data 
Discover 
